Clinical Features of 294 Turkish Patients with Chronic Myeloproliferative Neoplasms

Creative Commons License

ANDIÇ N., ÜNÜBOL M., Yagci E., Akay O. M., YAVAŞOĞLU İ., KADIKÖYLÜ V. G., ...Daha Fazla

TURKISH JOURNAL OF HEMATOLOGY, cilt.33, sa.3, ss.187-195, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 33 Sayı: 3
  • Basım Tarihi: 2016
  • Doi Numarası: 10.4274/tjh.2015.0041
  • Dergi Adı: TURKISH JOURNAL OF HEMATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.187-195
  • Anahtar Kelimeler: Myeloproliferative neoplasms, Survival, Thrombosis, Treatment, TYROSINE KINASE JAK2, ESSENTIAL THROMBOCYTHEMIA, POLYCYTHEMIA-VERA, RISK-FACTORS, PROGNOSTIC-FACTORS, LIFE EXPECTANCY, THROMBOSIS, MYELOFIBROSIS, MUTATION, HYDROXYUREA
  • Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

Objective: Myeloproliferative neoplasms (MPNs) share common clonal stem cells but show significant differences in their clinical courses. The aim of this retrospective study was to evaluate thrombotic and hemorrhagic complications, JAK2 status, gastrointestinal and cardiac changes, treatment modalities, and survival in MPNs in Turkish patients.